Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety and Antiviral Activity of Clevudine in Patients Infected With Hepatitis B Virus

This study has been terminated.
Sponsor:
Information provided by:
Bukwang Pharmaceutical
ClinicalTrials.gov Identifier:
NCT00305019
First received: March 17, 2006
Last updated: April 11, 2006
Last verified: April 2006
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: March 2004
  Estimated Primary Completion Date: No date given
No publications provided by Bukwang Pharmaceutical

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):